Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors
about
Regulation of Ste20-like kinase, SLK, activity: Dimerization and activation segment phosphorylation.Experience with erlotinib in the treatment of non-small cell lung cancer.Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
P2860
Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@ast
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@en
type
label
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@ast
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@en
prefLabel
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@ast
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@en
P2093
P2860
P1476
Differential Effects of Tyrosi ...... aling and Downstream Effectors
@en
P2093
BeiBei Luo
Jeffrey E Settleman
Karen S Anderson
Mihaela Apetri
Youngjoo Kim
P2860
P304
P356
10.1158/1541-7786.MCR-14-0326
P577
2015-01-08T00:00:00Z